This post is for paying subscribers only
Already have an account? Sign in.
Soleno Therapeutics: Patient Death and Vykat XR Scrutiny
Soleno's stock dipped after a PWS patient died. Company & doctor say death (pulmonary embolus) was unrelated to VYKAT XR, citing patient's co-morbidities & PWS risks.